Serum Pyridoxal Concentrations in Patients with Diabetic Neuropathy
- 28 June 1978
- journal article
- research article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 8 (3) , 259-261
- https://doi.org/10.1111/j.1445-5994.1978.tb04520.x
Abstract
Summary: Serum pyridoxal concentrations in patients with diabetic neuropathy.Serum pyridoxal (vitamin B6) concentrations were measured in 50 patients with significant diabetic neuropathy. There were 24 males and 26 females with a mean age of 58·2 years and a mean duration of diabetes of 9·8 years. The level of pyridoxal was significantly lower in these patients when compared with randomly selected diabetic patients matched for age and sex without clinical evidence of neuropathy. There was no significant difference in the duration of the diabetes between the two groups. The results indicate an association between pyridoxal deficiency and neuropathy in diabetic patients.This publication has 20 references indexed in Scilit:
- Diabetic Polyneuropathy: The Importance of Insulin Deficiency, Hyperglycemia and Alterations in Myoinositol Metabolism in Its PathogenesisNew England Journal of Medicine, 1976
- Serum pyridoxal and folate concentrations in diabeticsPathology, 1976
- An automated method for the microbiological assay of serum pyridoxalJournal of Clinical Pathology, 1973
- THE PATHOLOGY OF DIABETIC NEUROPATHYQJM: An International Journal of Medicine, 1966
- SCHWANN-CELL ABNORMALITIES IN DIABETIC NEUROPATHYThe Lancet, 1965
- Diabetic Neuropathy: a Metabolic or a Vascular Disease?Diabetes, 1965
- Multiple Deficiency State Associated with Isoniazid TherapyBMJ, 1964
- DIABETIC NEUROPATHY: A CONSIDERATION OF FACTORS IN ONSETAnnals of Internal Medicine, 1960
- Studies on the Pathogenesis of Diabetic NeuropathyActa Medica Scandinavica, 1956
- PERIPHERAL NEUROPATHY DUE TO ISONIAZID REPORT OF TWO CASESThe Lancet, 1953